首页> 外文期刊>BioMed research international >Sweetening Pharmaceutical Radiochemistry by ~(18)F-Fluoroglycosylation: A Short Review
【24h】

Sweetening Pharmaceutical Radiochemistry by ~(18)F-Fluoroglycosylation: A Short Review

机译:〜(18)F-氟糖基化对药物放射化学的增甜作用:简述

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

At the time when the highly efficient [~(18)F] FDG synthesis was discovered by the use of the effective precursor 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-beta-D-mannopyranose (mannose triflate) for nucleophilic ~(18)F-substitution, the field of PET in nuclear medicine experienced a long-term boom. Thirty years later, various strategies for chemoselective ~(18)F-labeling of biomolecules have been developed, trying to keep up with the emerging field of radiopharmaceutical sciences. Among the new radiochemical strategies, chemoselective ~(18)F-fluoroglycosylation methods aim at the sweetening of pharmaceutical radiochemistry by providing a powerful and highly valuable tool for the design of ~(18)F-glycoconjugates with suitable in vivo properties for PET imaging studies. This paper provides a short review (reflecting the literature not older than 8 years) on the different ~(18)F-fluoroglycosylation reactions that have been applied to the development of various ~(18)F-glycoconjugate tracers, including not only peptides, but also nonpeptidic tracers and high-molecular-weight proteins.
机译:当通过使用有效的前体1,3,4,6-四-O-乙酰基-2-O-三氟甲磺酰基-β-D-甘露吡喃糖发现高效的[〜(18)F] FDG合成时(三氟甲磺酸甘露糖)用于亲核〜(18)F取代,核医学领域的PET领域经历了长期的繁荣。 30年后,已开发出多种生物分子化学选择性〜(18)F标记的策略,以跟上放射性药物科学的新兴领域。在新的放射化学策略中,化学选择性〜(18)F-氟糖基化方法旨在通过提供功能强大且极有价值的工具来设计〜(18)F-糖基偶联物,从而为PET成像研究提供适合的体内特性,从而实现药物放射化学的甜化。 。本文提供了简短的综述(反映了不超过8年的文献),探讨了不同的〜(18)F-氟糖基化反应已用于开发各种〜(18)F-糖缀合物示踪剂,不仅包括肽,以及非肽示踪剂和高分子量蛋白质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号